Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7937562rdf:typepubmed:Citationlld:pubmed
pubmed-article:7937562lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7937562lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:7937562lifeskim:mentionsumls-concept:C0057676lld:lifeskim
pubmed-article:7937562pubmed:issue6lld:pubmed
pubmed-article:7937562pubmed:dateCreated1994-11-1lld:pubmed
pubmed-article:7937562pubmed:abstractText2,3-Butanedione monoxime, also known as diacetyl monoxime, is a nucleophilic agent which dephosphorylates acetylcholinesterase poisoned with organophosphates. This "chemical phosphatase" activity stimulated studies of the effect of 2,3-butanedione monoxime on phosphorylation-dependent cellular processes. As a result of these studies, we know that the drug affects a number of mechanisms including muscle contraction, ionic current flow and synaptic transmission. Furthermore, it may be used as a component of cardioplegic solutions since it protects cardiac tissue exposed to certain ischaemic conditions. While this MiniReview reveals the diversity of its cellular actions, there continues to be unresolved questions regarding its molecular mechanism.lld:pubmed
pubmed-article:7937562pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7937562pubmed:languageenglld:pubmed
pubmed-article:7937562pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7937562pubmed:citationSubsetIMlld:pubmed
pubmed-article:7937562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7937562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7937562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7937562pubmed:statusMEDLINElld:pubmed
pubmed-article:7937562pubmed:monthJunlld:pubmed
pubmed-article:7937562pubmed:issn0901-9928lld:pubmed
pubmed-article:7937562pubmed:authorpubmed-author:SellinL CLClld:pubmed
pubmed-article:7937562pubmed:authorpubmed-author:McArdleJ JJJlld:pubmed
pubmed-article:7937562pubmed:issnTypePrintlld:pubmed
pubmed-article:7937562pubmed:volume74lld:pubmed
pubmed-article:7937562pubmed:ownerNLMlld:pubmed
pubmed-article:7937562pubmed:authorsCompleteYlld:pubmed
pubmed-article:7937562pubmed:pagination305-13lld:pubmed
pubmed-article:7937562pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7937562pubmed:meshHeadingpubmed-meshheading:7937562-...lld:pubmed
pubmed-article:7937562pubmed:meshHeadingpubmed-meshheading:7937562-...lld:pubmed
pubmed-article:7937562pubmed:meshHeadingpubmed-meshheading:7937562-...lld:pubmed
pubmed-article:7937562pubmed:meshHeadingpubmed-meshheading:7937562-...lld:pubmed
pubmed-article:7937562pubmed:meshHeadingpubmed-meshheading:7937562-...lld:pubmed
pubmed-article:7937562pubmed:meshHeadingpubmed-meshheading:7937562-...lld:pubmed
pubmed-article:7937562pubmed:meshHeadingpubmed-meshheading:7937562-...lld:pubmed
pubmed-article:7937562pubmed:meshHeadingpubmed-meshheading:7937562-...lld:pubmed
pubmed-article:7937562pubmed:meshHeadingpubmed-meshheading:7937562-...lld:pubmed
pubmed-article:7937562pubmed:year1994lld:pubmed
pubmed-article:7937562pubmed:articleTitleMultiple effects of 2,3-butanedione monoxime.lld:pubmed
pubmed-article:7937562pubmed:affiliationDepartment of Biophysics, University of Oulu, Finland.lld:pubmed
pubmed-article:7937562pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7937562pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7937562pubmed:publicationTypeReviewlld:pubmed
pubmed-article:7937562pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7937562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7937562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7937562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7937562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7937562lld:pubmed